Covered recipient · General Payments record
KATHLEEN A HALLINAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$682.16
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $383.65 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $285.30 | 12 |
| Novo Nordisk AS | $50.30 | 3 |
| Exact Sciences Corporation | $48.05 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.68 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867171 | CMS |
| ABBVIE INC. | $19.02 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867173 | CMS |
| ABBVIE INC. | $28.74 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867175 | CMS |
| ABBVIE INC. | $26.41 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867177 | CMS |
| ABBVIE INC. | $20.66 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867179 | CMS |
| ABBVIE INC. | $17.48 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867181 | CMS |
| ABBVIE INC. | $19.39 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867183 | CMS |
| ABBVIE INC. | $34.20 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867185 | CMS |
| ABBVIE INC. | $28.06 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867187 | CMS |
| ABBVIE INC. | $21.89 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867189 | CMS |
| ABBVIE INC. | $21.49 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867191 | CMS |
| ABBVIE INC. | $24.28 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103867193 | CMS |
| Exact Sciences Corporation | $20.66 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114690162 | CMS |
| Exact Sciences Corporation | $27.39 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114690157 | CMS |
| Novo Nordisk Inc | $21.53 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097113833 | CMS |
| Novo Nordisk Inc | $13.91 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097201690 | CMS |
| Novo Nordisk Inc | $14.86 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096614836 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.